Home › Companies › Strata Critical Medical, Inc. › 2025-2026

Strata Critical Medical, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Strata Critical Medical, Inc.’s Form 8-K, filed 2026-06-03 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 4Ballot items
  • 137Asset managers
  • 618Fund votes
  • 2026-05-28Meeting date

Proxy season: 2025-2026

Explore Strata Critical Medical, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Strata Critical Medical, Inc.

These tallies are Strata Critical Medical, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-03 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Strata Critical Medical, Inc. — official shareholder meeting results, meeting held 2026-05-28
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: William A. Heyburn 46,050,902---- 505,42112,687,496 Majority: yes
Elect Director: Andrew Lauck 39,525,159---- 7,031,16412,687,496 Majority: yes
Proposal 2: The Company's stockholders ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. 58,946,83265,815231,172 ---- Majority: yes
Proposal 3: The Company's stockholders approved, on an advisory, non-binding basis, the compensation of the Company's named executive officers (the "Say-on-Pay" vote). 38,497,9628,022,68235,679 --12,687,496 Majority: yes

Source: Strata Critical Medical, Inc., Form 8-K, filed with the SEC on 2026-06-03 — read the filing on EDGAR.

How asset managers voted at the Strata Critical Medical, Inc. 2025-2026 meeting

Each item below shows how the 137 asset managers that disclosed a Strata Critical Medical, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Advisory Vote on the Compensation of our Named Executive Officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%AGAINST 17%
FOR: 38,497,962AGAINST: 8,022,682

Strata Critical Medical, Inc.’s own tally for this item (“Proposal 3: The Company's stockholders approved, on an advisory, non-binding basis, the compensation of the Company's named executive officers (the "Say-on-Pay" vote).”): 38,497,962 for, 8,022,682 against, per its Form 8-K filed 2026-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 86,526,570 outstanding shares: 44% for, 9% against (53.8% of the company cast a for/against vote).

The 137 asset managers below cast 73% of the shares they voted on this item FOR (26,923,142 for, 9,897,037 against).

FOR 73%AGAINST 27%
FOR: 26,923,142 (73.1%)AGAINST: 9,897,037 (26.9%)
Largest asset managers voting on “Advisory Vote on the Compensation of our Named Executive Officers.” at Strata Critical Medical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust7,369,7900 00For
Third Point5,000,0000 00For
Vanguard2,806,507516,821 00For
Northern Right Capital Management, L.P.3,069,3250 00For
Royce2,760,9000 00For
First Eagle Investment Management, LLC02,266,243 00Against
FIRST EAGLE FUNDS01,961,041 00Against
BlackRock1,908,22521,107 00For
Amova Asset Management Co., Ltd.01,654,361 00Against
Uniplan Investment Counsel, Inc.1,007,8970 00For
ARK Investment Management LLC712,5240 00For
Newton Investment Management North America, LLC611,6440 00For
Dimensional0559,527 00Against
State Street477,4221,491 00For
Russell Investments0409,971 00Against
Charles Schwab0403,365 00Against
American Century0317,496 00Against
BNY Mellon312,9900 00For
Northern Trust0256,827 00Against
MELLON INVESTMENTS Corp144,3250 00For
Goldman Sachs130,9220 00For
PRINCIPAL GLOBAL INVESTORS0128,411 00Against
Principal Exchange-Traded Funds0125,339 00Against
STATE OF WISCONSIN INVESTMENT BOARD0118,359 00Against
Nuveen117,4540 00For

Showing the 25 largest of 137 asset managers. See all 137 in the interactive database.

2. Elect Class II Directors for terms expiring in 2029: Andrew Lauck

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%WITHHELD 15%
FOR: 39,525,159WITHHELD: 7,031,164

Strata Critical Medical, Inc.’s own tally for this item (“Elect Director: Andrew Lauck”): 39,525,159 for, 7,031,164 withheld, per its Form 8-K filed 2026-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 86,526,570 outstanding shares: 45.7% for, 8% withheld (53.8% of the company cast a for/withheld vote).

The 46 asset managers below cast 100% of the shares they voted on this item FOR (14,813,867 for, 0 against).

FOR 83%ABSTAIN 17%
FOR: 14,813,867 (82.7%)ABSTAIN: 3,094,017 (17.3%)
Largest asset managers voting on “Elect Class II Directors for terms expiring in 2029: Andrew Lauck” at Strata Critical Medical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust7,369,7900 00For
Vanguard3,008,6260 120For
Royce2,195,5810 00For
FIRST EAGLE FUNDS00 1,961,0410Abstain
BlackRock1,284,1180 00For
Dimensional00 470,3180Abstain
BNY Mellon312,9900 00For
Charles Schwab201,5570 00For
American Century00 158,7480Abstain
Russell Investments143,6830 00For
Principal Exchange-Traded Funds00 125,3390Abstain
TIAA00 106,5090Abstain
JPMorgan97,7210 00For
Equitable32,0300 49,5300Abstain
Lincoln Financial00 49,9270Abstain
Fidelity37,2530 00For
AIG/SunAmerica00 33,1880Abstain
Global X32,4690 00For
Pacific Life30,2330 00For
Bridge Builder Trust29,6910 00For
Venerable Variable Insurance Trust5,3110 21,1890Abstain
Jackson National00 25,3490Abstain
Virtus00 22,1360Abstain
AQR00 15,7810Abstain
Goldman Sachs14,0290 00For

Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.

3. Elect Class II Directors for terms expiring in 2029: William A. Heyburn

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 46,050,902WITHHELD: 505,421

Strata Critical Medical, Inc.’s own tally for this item (“Elect Director: William A. Heyburn”): 46,050,902 for, 505,421 withheld, per its Form 8-K filed 2026-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 86,526,570 outstanding shares: 53.2% for, 0.6% withheld (53.8% of the company cast a for/withheld vote).

The 46 asset managers below cast 100% of the shares they voted on this item FOR (17,857,945 for, 0 against).

FOR 99.7%
FOR: 17,857,945 (99.7%)ABSTAIN: 49,939 (0.3%)
Largest asset managers voting on “Elect Class II Directors for terms expiring in 2029: William A. Heyburn” at Strata Critical Medical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust7,369,7900 00For
Vanguard3,006,2700 2,3680For
Royce2,195,5810 00For
FIRST EAGLE FUNDS1,961,0410 00For
BlackRock1,284,1180 00For
Dimensional470,3180 00For
BNY Mellon312,9900 00For
Charles Schwab201,5570 00For
American Century158,7480 00For
Russell Investments143,6830 00For
Principal Exchange-Traded Funds125,3390 00For
TIAA106,5090 00For
JPMorgan97,7210 00For
Equitable81,5600 00For
Lincoln Financial49,9270 00For
Fidelity37,2530 00For
AIG/SunAmerica33,1880 00For
Global X00 32,4690Abstain
Pacific Life30,2330 00For
Bridge Builder Trust29,6910 00For
Venerable Variable Insurance Trust26,5000 00For
Jackson National25,3490 00For
Virtus22,1360 00For
AQR15,7810 00For
Goldman Sachs14,0290 00For

Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.

4. RATIFY APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2026 (DELOITTE & TOUCHE LLP).

AUDIT-RELATEDMajority of the votes cast: yes

99.8% Majority: yes · of votes cast

FOR 99.8%
FOR: 58,946,832AGAINST: 65,815

Strata Critical Medical, Inc.’s own tally for this item (“Proposal 2: The Company's stockholders ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”): 58,946,832 for, 65,815 against, per its Form 8-K filed 2026-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 86,526,570 outstanding shares: 68% for, 0.1% against (68% of the company cast a for/against vote).

The 46 asset managers below cast 100% of the shares they voted on this item FOR (17,907,884 for, 0 against).

FOR 100%
FOR: 17,907,884 (100.0%)
Largest asset managers voting on “RATIFY APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2026 (DELOITTE & TOUCHE LLP).” at Strata Critical Medical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust7,369,7900 00For
Vanguard3,008,6380 00For
Royce2,195,5810 00For
FIRST EAGLE FUNDS1,961,0410 00For
BlackRock1,284,1180 00For
Dimensional470,3180 00For
BNY Mellon312,9900 00For
Charles Schwab201,5570 00For
American Century158,7480 00For
Russell Investments143,6830 00For
Principal Exchange-Traded Funds125,3390 00For
TIAA106,5090 00For
JPMorgan97,7210 00For
Equitable81,5600 00For
Lincoln Financial49,9270 00For
Fidelity37,2530 00For
AIG/SunAmerica33,1880 00For
Global X32,4690 00For
Pacific Life30,2330 00For
Bridge Builder Trust29,6910 00For
Venerable Variable Insurance Trust26,5000 00For
Jackson National25,3490 00For
Virtus22,1360 00For
AQR15,7810 00For
Goldman Sachs14,0290 00For

Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.

Largest Strata Critical Medical, Inc. shareholders voting in 2025-2026

Ranked by the number of Strata Critical Medical, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 86,526,570 shares outstanding at the time of that meeting.

Top Strata Critical Medical, Inc. shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1ARK ETF Trust 8.52%
2Third Point 5.78%
3Vanguard 3.84%
4Northern Right Capital Management, L.P. 3.55%
5Royce 3.19%
6First Eagle Investment Management, LLC 2.62%
7FIRST EAGLE FUNDS 2.27%
8BlackRock 2.23%
9Amova Asset Management Co., Ltd. 1.91%
10Uniplan Investment Counsel, Inc. 1.16%

Reported Strata Critical Medical, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Strata Critical Medical, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
Steele ExpCo Holdings, LLC 9.16% 13G
BlackRock 5.28% 13F
Vanguard Group 4.20% 13F
ARK Investment Management LLC 3.16% 13G
Dimensional Fund Advisors 1.87% 13F
State Street 1.56% 13F
BNY Mellon 1.25% 13F
Morgan Stanley 0.89% 13F
Northern Trust 0.74% 13F
Renaissance Technologies 0.55% 13F

Percentages above are of 86,526,570 shares outstanding, as reported by Strata Critical Medical, Inc. on its Form 10-Q dated 2026-04-27 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Strata Critical Medical, Inc.’s 10-Q dated 2026-04-27. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Strata Critical Medical, Inc.'s shareholder meeting held 2026-05-28, in the 2025-2026 proxy season, 137 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 618 separate fund positions. On the most widely held item on that ballot — Advisory Vote on the Compensation of our Named Executive Officers. — FOR was 83% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Strata Critical Medical, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-06-03.

Strata Critical Medical, Inc. proxy season coverage: 2025-2026 (this page).